December 18, 2012
Takeda Pharmaceutical Co is selling its USA-based URL Pharma generic business, ie excluding the gout drug Colcrys, to Sun Pharmaceutical Industries' Caraco unit
May 15, 2012
Japanese drugmaker Takeda saw its stock slide more than 5% after revealing a profit forecast for 2012 languishing well below market expectations.
April 12, 2012
Takeda has forked out $800 million to acquire US-based gout specialist URL Pharma in its bid to expand in the states – however, some analysts have found the deal baffling.
PharmaTimes 2013 Copyright | RSS Feed Subscriptions